Cerity Partners
IART icon

Cerity Partners’s Integra LifeSciences IART Stock Holding History

Cerity Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,622
Closed -$194K – 3317
2025
Q4 		$194K Sell
15,622
-883
-5% -$11.7K ﹤0.01% 2645
2025
Q3 		$237K Buy
+16,505
New +$226K ﹤0.01% 2418
2024
Q3 		– Sell
-13,949
Closed -$406K – 2570
2024
Q2 		$406K Buy
13,949
+5,416
+63% +$161K ﹤0.01% 1646
2024
Q1 		$302K Buy
8,533
+1,841
+28% +$73.6K ﹤0.01% 1863
2023
Q4 		$291K Buy
+6,692
New +$263K ﹤0.01% 1533
2023
Q3 		– Sell
-10,755
Closed -$442K – 1538
2023
Q2 		$442K Buy
+10,755
New +$518K ﹤0.01% 1232

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cerity Partners's IART Position: Q1 2026 in Review

Cerity Partners sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 15,622 shares — an estimated $194K sold.

Cerity Partners first reported a position in IART in Q2 2023 and held it in 6 quarters. The position peaked at $442K in Q2 2023. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Cerity Partners reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Cerity Partners sold 15,622 Integra LifeSciences shares in Q1 2026, an estimated $194K.
  • Cerity Partners first reported a position in Integra LifeSciences in Q2 2023 and held it in 6 quarters.
  • Cerity Partners's Integra LifeSciences position peaked at $442K in Q2 2023.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.